RLMDNasdaq United States
Market cap
$518.158 M
$4.94 -8.01%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
$0.00
#2497 by earnings
Shares outstanding
106,669,846
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Relmada Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.